SB4928 - District of Columbia Appropriations Act, 2025 Judiciary Appropriations Act, 2025 Executive Office of the President Appropriations Act, 2025 Department of the Treasury Appropriations Act, 2025

1 Co-Sponsor

An original bill making appropriations for financial services and general government for the fiscal year ending September 30, 2025, and for other purposes.

SR296 - A resolution designating July 2023 as "Plastic Pollution Action Month".

3 Co-Sponsors

SR201 - A resolution supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2023.

29 Co-Sponsors

SR282 - A resolution recognizing June 2023 as "LGBTQ Pride Month".

50 Co-Sponsors

SR191 - A resolution recognizing widening threats to freedom of the press and free expression around the world, reaffirming the vital role that a free and independent press plays in combating the growing threats of authoritarianism, misinformation, and disinformation, and reaffirming freedom of the press as a priority of the United States Government in promoting democracy, human rights, and good governance in commemoration of World Press Freedom Day on May 3, 2023.

7 Co-Sponsors

SR211 - A resolution expressing the sense of the Senate that public servants should be commended for their dedication and continued service to the United States during Public Service Recognition Week.

13 Co-Sponsors

SB3013 - A bill to permanently authorize the exemption of aliens working as fish processors from the numerical limitation on H-2B nonimmigrant visas.

9 Co-Sponsors

SB4440 - Public Housing Emergency Response Act

10 Co-Sponsors

A bill to authorize additional monies to the Public Housing Capital Fund of the Department of Housing and Urban Development, and for other purposes.

SB2176 - Therapeutic Fraud Prevention Act of 2023

46 Co-Sponsors

A bill to prohibit commercial sexual orientation conversion therapy, and for other purposes.

SB4774 - Better Care for PFAS Patients Act of 2024

3 Co-Sponsors

A bill to provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes.